Price Target in Focus: $300 represents a psychologically important round number, roughly 62% above the most recent closing price of $184.89 and a level the stock previously traded above as recently as June 2026. Bullish Catalysts: A $25 billion expanded partnership with Brookfield Asset Management for AI infrastructure, a 2.8-gigawatt Oracle agreement, and first-quarter 2026 revenue that surged 130% year-over-year to $751 million.

Bloom Energy shares dropped approximately 26.6% over the trailing 30 days, closing at $184.89 on July 24, 2026, down from $252.02 on June 26. A short-seller report from Hunterbrook Capital on July 7, targeting the company's scandium supply chain, triggered the initial wave of selling pressure.

BW shares fell approximately 33% over the past 30 days, dropping from $14.45 on June 26 to $9.62 by July 24, 2026, as multiple headwinds converged on the stock. Ongoing securities class action lawsuits tied to the $2.4 billion Base Electron power generation contract continue to weigh heavily on investor sentiment and raise governance concerns.

Rocket Lab shares closed at $63.91 on July 24, 2026, meaning the stock would need to climb approximately 56% to reclaim the psychologically significant $100 level. The strongest bullish catalyst is Neutron, the company's medium-lift reusable rocket targeting a debut launch in the fourth quarter of 2026, which could unlock a $5.6 billion national security launch program and dramatically expand the revenue base.

Price Target: The $140 level represents a critical psychological round-number target for the USO ETF, sitting roughly 17% above recent trading levels and below the 52-week high of $154.08 reached in May 2026. Bullish Catalyst: Ongoing geopolitical tension surrounding the Strait of Hormuz continues to constrain roughly 20% of global oil supply, providing a structural underpinning for elevated crude prices and by extension USO.

Intercontinental Exchange (ICE) shares surged approximately +17% over the past 30 days, climbing from a closing low of $124.49 on June 25, 2026, to $145.79 on July 24, 2026. The rally was fueled by a series of strategic product announcements, including GPU compute futures tied to AI infrastructure and new economic indicator contracts, which refocused investor attention on ICE's innovation pipeline.

Intel shares fell approximately 30.5% over the last 30 days, dropping from $132.87 on June 25 to $92.32 on July 24, 2026, erasing roughly $90 billion in market capitalization. The decline occurred despite Intel reporting its strongest quarterly revenue growth in more than 15 years, with Q2 revenue of $16.1 billion up 25% year-over-year and EPS of $0.42 nearly doubling consensus estimates.

Vertiv (VRT) shares declined roughly 8.2% over the past 30 days, pulling back from elevated levels after a 106% surge in the first half of 2026. The company remains a dominant pure-play AI data center infrastructure provider, with approximately 85% of sales tied to the data center sector and a record $15 billion backlog.

Applied Materials shares declined approximately 19.7% between June 25 and July 24, 2026, falling from $668.00 to $536.25 as a sector-wide semiconductor sell-off took hold. The stock remains up roughly 28.6% over the trailing quarter despite the recent pullback, reflecting the powerful AI-driven rally that propelled AMAT to an all-time high of $739.67 on June 30.

Tesla shares dropped approximately 16.6% in the last 30 days, falling from $375.12 on June 25 to $313.03 on July 24, 2026. Second-quarter earnings released on July 22 badly missed profit expectations, with adjusted EPS of $0.33 versus the $0.51 consensus estimate.

Oracle shares have fallen 24.6% over the past 30 days, plunging from $152.46 on June 25 to $114.99 on July 24, hitting fresh 52-week lows. The sell-off accelerated after S&P Global Ratings downgraded Oracle's credit rating to BBB- on July 9, one notch above junk status, citing unsustainable AI infrastructure spending.

Intuitive Surgical shares dropped approximately 15% over the past 30 days, accelerating sharply after the company's second-quarter 2026 earnings report released on July 16. Q2 revenue rose 19% year-over-year to $2.89 billion and adjusted EPS of $2.80 beat Wall Street estimates, yet investors focused on unchanged full-year procedure growth guidance.

KLA Corporation (KLAC) shares declined approximately 18.7% over the past 30 days, falling from $258.80 on June 25 to $210.52 on July 24. The stock hit an all-time high of $301.71 on June 30 before a sharp reversal triggered by insider selling, valuation concerns, and broad semiconductor sector rotation.

LegalZoom.com (LZ) shares surged approximately 24% over the last 30 days, rebounding sharply from a 52-week low of $5.22 reached in late June. The recovery was fueled by easing AI disruption fears, strong first-quarter results that beat revenue expectations, and raised full-year 2026 guidance.

NBIS plunged approximately -12.82% during Friday's regular session, dropping from a prior close of $220.97 to about $192.65, as the neocloud trade suffered a broad sector-wide unwind. The primary catalyst was a risk-off rotation out of high-multiple AI infrastructure names, with peer CoreWeave (CRWV) also declining sharply, while the Nasdaq trailed the broader market.

LBRT shares fell another -11.06% during regular trading on Friday, extending Thursday's -22% post-earnings collapse for a combined two-day loss of roughly -30%. The selloff was triggered by the company's Q2 earnings call, where CFO Michael Stock revealed a ~50% increase in 2026 capex to approximately $1.5 billion, driven by deposits on long-lead-time power generation equipment.

AEHR tumbled -12.04% during regular trading on Friday, extending a multi-session slide from its post-earnings peak of $98.91 on July 21 to approximately $77.85. The selloff reflects aggressive profit-taking after the stock surged over +40% following its July 14 blowout fiscal Q4 earnings report and FY2027 revenue guidance of $130M–$150M, implying 160%–200% year-over-year growth.

HIMS plunged -13.10% during regular trading on Friday, erasing Thursday's +3.35% FDA-driven gain and hitting intraday lows near $28.41. The primary catalyst was a healthcare sector sell-off triggered by HCA Healthcare's earnings report, which flagged a "negative payer mix shift" from rising uninsured patients that reduced pre-tax income by $400 million.

T1 Energy shares plunged -13.03% to $4.94 during regular trading Thursday, extending a brutal month-long selloff that has now halved the stock from its late-June highs near $10. The primary catalyst is a newly disclosed regulatory probe into the company's safety practices, compounded by short-seller allegations that T1 relied on banned Chinese suppliers in its solar manufacturing operations.

NVEC is trading at approximately $113.88 during today's regular session, down -15.15% from yesterday's close of $134.21, as heavy profit-taking sets in after an explosive two-day rally. The selloff follows an extraordinary +54.83% single-day surge on July 23, triggered by blowout Q1 FY2027 earnings reported after the July 22 close — revenue surged +81% YoY to $11.0 million and net income jumped +79% to $6.39 million.